Corneal Crosslinking (CXL) is a treatment designed mainly to increase the biomechanical strength of the cornea and reduce the risk of keratoconus progression.
Its main goal is not to immediately eliminate your prescription or to guarantee improved visual acuity. Its most important function is to stabilize the structure of the cornea when there is evidence that the keratoconus is still advancing.
This is especially important in young patients, in whom the disease can progress more rapidly.
The specialist reviews several corneal studies in order to determine:
TECHNOLOGY + SAFETY + EXPERIENCE
To answer your questions and give you the information you need about your treatment, please fill out the form and we will reply to your request as soon as possible.
We will reply to the email address or phone number you give us.
We hold the international Ambulatory Surgery Center Accreditation granted by ACHC, a leader in the United States and worldwide, which backs our quality and safety standards.